Pharmacokinetics and safety of the ketolide telithromycin in patients with renal impairment.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000097:blood / Q000493:pharmacokinetics*; D019540:Area Under Curve; D018592:Cross-Over Studies; D004562:Electrocardiography; D005260:Female; D006207:Half-Life; D006801:Humans; D048628:Ketolides; D007674:Kidney Diseases / Q000378:metabolism*; D018942:Macrolides / Q000009:adverse effects* / Q000097:blood / Q000493:pharmacokinetics*; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D013997:Time Factors
D000900:Anti-Bacterial Agents; D048628:Ketolides; D018942:Macrolides; C106791:telithromycin